Actinium Pharmaceuticals, Inc. (ATNM)

Revenue

$35.00M

Quarterly · Period ending: · USD

ATNM logo

ATNM Revenue

Latest reported$35.00M
ATNM Quarterly Revenue ($0.00 → $35.00M)
High-resolution chart · PNG

ATNM revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Actinium Pharmaceuticals, Inc. Revenue — Quarterly (USD)
Period endingRevenue (USD)
35,000,000
0
0
90,000
0
0
0
0
0
0
81,000
0
0
0
0
45,000
45,000
940,000
23,000
233,000
266,000
622,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,444
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.